Skip to content

Clinical trials

Phase 2 Candidiasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Candidiasis Phase: Phase 2 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20042
20061
20081
20104
20111
20162
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
Pfizer3
Almirall, S.A.1
Astellas Pharma Inc1
Basilea Pharmaceutica1
Ferrer Internacional S.A.1
Kerman University of Medical Sciences1
National Institute of Allergy and Infectious Diseases (NIAID)1
Schering-Plough1
Toltec Pharmaceuticals, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Candidiasis17
Candidemia4
Candidiasis, Invasive4
Aspergillosis3
Candidiasis, Vulvovaginal3
Mycoses2
Vaginosis, Bacterial2
AIDS-Related Opportunistic Infections1
Candidiasis, Oral1
Cryptococcosis1

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.